{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T15:01:07Z","timestamp":1749999667677,"version":"3.40.5"},"reference-count":119,"publisher":"Informa UK Limited","issue":"14","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2021,12,6]]},"DOI":"10.1080\/10428194.2021.1964022","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T13:12:32Z","timestamp":1629205952000},"page":"3333-3347","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Antibody and cellular immunotherapies for acute lymphoblastic leukemia in adults"],"prefix":"10.1080","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1885-1773","authenticated-orcid":false,"given":"Erik L.","family":"Kimble","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA"},{"name":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3424-2425","authenticated-orcid":false,"given":"Ryan D.","family":"Cassaday","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA"},{"name":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,8,17]]},"reference":[{"key":"CIT0001","unstructured":"Cancer Stat Facts: leukemia - acute lymphocytic leukemia (ALL) [Internet]. Bethesda (MD): National Cancer Institute. 2021. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/alyl.html#:\u223c:text=At%20a%20Glance%20%20%20%20Year%20,%20%201.84%20%2034%20more%20rows%20"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.1915"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-445098"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V75.3.555.555"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1605085"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.9456"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30144-7"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1080\/08820130500496878"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-438002"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.206"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509277"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32116"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.04.020"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.2380"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.7512"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30103-5"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-017-0019-y"},{"key":"CIT0018","unstructured":"ClinicalTrials.gov. A study of two inotuzumab ozogamicin doses in relapsed\/refractory acute lymphoblastic leukemia transplant eligible patients [Internet]. Bethesda (MD): US National Institutes of Health; [cited 2021 Apr 09]. Available from: https:\/\/ClinicalTrials.gov\/Q6show\/NCT03677596."},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01222-8"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30011-1"},{"issue":"1","key":"CIT0021","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1182\/blood-2020-136920","volume":"136","author":"Stelljes M","year":"2020","journal-title":"Blood"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1038\/314628a0"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1126\/science.1158545"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.6.2098"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1084\/jem.168.3.1205"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1006\/smim.1998.9999"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.1.73"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-129600"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609783"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.69.3531"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32558"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32335"},{"issue":"2","key":"CIT0033","doi-asserted-by":"crossref","first-page":"LBA-1","DOI":"10.1182\/blood-2019-132435","volume":"134","author":"Brown PA","year":"2019","journal-title":"Blood"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0580"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-798322"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-111516"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-111992"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2016272"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30167-X"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01389"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01056"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002403"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0813"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12357"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-131061"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-111845"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-112572"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-116745"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-119502"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2012.06.004"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061283"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0164-6"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050732"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1038\/nm1312"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2004.12.003"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1172\/JCI32205"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85309"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf8621"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-883710"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-887067"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-281931"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-348540"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103849"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709919"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61403-3"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01892"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000692"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804980"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31366-0"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1914347"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002842"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407222"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2035"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01222-8"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2020.1729735"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001511"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000952"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-793760"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1697814"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.10.049"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2020.04.012"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006770"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1049"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0290-5"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0178-z"},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.1038\/nature21405"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-137768"},{"key":"CIT0091","unstructured":"ClinicalTrials.gov. TC-110 T cells in adults with relapsed or refractory non-hodgkin lymphoma or acute lymphoblastic leukemia [Internet]. Bethesda (MD): US National Institutes of Health; [cited 2021 Apr 09]. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04323657."},{"key":"CIT0092","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-1020"},{"key":"CIT0093","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000169"},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0146-z"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-08-665547"},{"key":"CIT0096","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12320"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0201-9"},{"key":"CIT0098","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4441"},{"key":"CIT0099","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw9414"},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003293"},{"key":"CIT0101","doi-asserted-by":"publisher","DOI":"10.1172\/JCI87366"},{"issue":"16","key":"CIT0102","first-page":"CT051","volume":"80","author":"Shalabi H","year":"2020","journal-title":"Proc AACR 2020"},{"key":"CIT0103","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00146"},{"key":"CIT0104","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000593"},{"key":"CIT0105","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.09.002"},{"key":"CIT0106","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.04.003"},{"key":"CIT0107","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.608916"},{"key":"CIT0108","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-794214"},{"key":"CIT0109","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0548-z"},{"key":"CIT0110","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.197640"},{"key":"CIT0111","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-018-0222-5"},{"key":"CIT0112","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28829"},{"key":"CIT0113","unstructured":"ClinicalTrials.gov. A study to evaluate the efficacy and safety of daratumumab in pediatric and young adult participants greater than or equal to (>=)1 and less than or equal to (<=) 30 years of age with relapsed\/refractory precursor B-cell or T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma [Internet]. Bethesda (MD): US National Institutes of Health; [cited 2021 Apr 09]. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT03384654."},{"key":"CIT0114","unstructured":"ClinicalTrials.gov. Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia [Internet]. Bethesda (MD): US National Institutes of Health; [cited 2021 Apr 09]. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT02999633."},{"key":"CIT0115","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0801-y"},{"key":"CIT0116","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-10-882944"},{"key":"CIT0117","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4444"},{"key":"CIT0118","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0065-5"},{"issue":"16","key":"CIT0119","first-page":"CT052","volume":"80","author":"Wang X","year":"2020","journal-title":"Proc AACR 2020"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2021.1964022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T12:52:37Z","timestamp":1639399957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2021.1964022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,17]]},"references-count":119,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2021,12,6]]}},"alternative-id":["10.1080\/10428194.2021.1964022"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2021.1964022","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"type":"print","value":"1042-8194"},{"type":"electronic","value":"1029-2403"}],"subject":[],"published":{"date-parts":[[2021,8,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-05-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}